Search Results - "LATHAM, Patricia S"

Refine Results
  1. 1

    Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis by Ahmed, Umbreen, Latham, Patricia S, Oates, Phillip S

    Published in World journal of gastroenterology : WJG (14-09-2012)
    “…The liver is an important site for iron and lipid metabolism and the main site for the interactions between these two metabolic pathways. Although conflicting…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Effects of rIL2/anti-IL2 antibody complex on chikungunya virus-induced chronic arthritis in a mouse model by Tritsch, Sarah R., Porzucek, Abigail J., Schwartz, Arnold M., Proctor, Abigale M., Amdur, Richard L., Latham, Patricia S., Simon, Gary L., Mores, Christopher N., Chang, Aileen Y.

    Published in Scientific reports (05-05-2023)
    “…Chikungunya virus (CHIKV) is characterized by disabling joint pain that can cause persistent arthritis in approximately one-fourth of patients. Currently, no…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study by Keating, Sheila M, Dodge, Jennifer L, Norris, Philip J, Heitman, John, Gange, Stephen J, French, Audrey L, Glesby, Marshall J, Edlin, Brian R, Latham, Patricia S, Villacres, Maria C, Greenblatt, Ruth M, Peters, Marion G

    Published in PloS one (13-09-2017)
    “…Hepatitis C virus infection induces inflammation and while it is believed that HIV co-infection enhances this response, HIV control may reduce inflammation and…”
    Get full text
    Journal Article
  7. 7

    A Mouse Model for Studying Post-Acute Arthritis of Chikungunya by Chang, Aileen Y, Tritsch, Sarah R, Porzucek, Abigail J, Schwartz, Arnold M, Seyler-Schmidt, Margaux, Glass, Arielle, Latham, Patricia S, Reid, St Patrick, Simon, Gary L, Mores, Christopher N

    Published in Microorganisms (Basel) (21-09-2021)
    “…Chikungunya virus (CHIKV) was introduced to the Americas in 2013, causing two million infections across over thirty countries. CHIKV causes a chronic…”
    Get full text
    Journal Article
  8. 8
  9. 9

    TRIM28 promotes luminal cell plasticity in a mouse model of prostate cancer by Yende, Ashutosh S., Williams, Emily C., Pletcher, Andrew, Helfand, Alexandra, Ibeawuchi, Helen, North, Tanya M., Latham, Patricia S., Horvath, Anelia, Shibata, Maho

    Published in Oncogene (21-04-2023)
    “…The Tripartite motif-containing 28 (TRIM28) transcriptional cofactor is significantly upregulated in high-grade and metastatic prostate cancers. To study the…”
    Get full text
    Journal Article
  10. 10

    Gut Colonization with Methanogenic Archaea Lowers Plasma Trimethylamine N-oxide Concentrations in Apolipoprotein e−/− Mice by Ramezani, Ali, Nolin, Thomas D., Barrows, Ian R., Serrano, Myrna G., Buck, Gregory A., Regunathan-Shenk, Renu, West, Raymond E., Latham, Patricia S., Amdur, Richard, Raj, Dominic S.

    Published in Scientific reports (03-10-2018)
    “…A mechanistic link between trimethylamine N-oxide (TMAO) and atherogenesis has been reported. TMAO is generated enzymatically in the liver by the oxidation of…”
    Get full text
    Journal Article
  11. 11

    Impaired reciprocal regulation between SIRT6 and TGF‐β signaling in fatty liver by Xiang, Xiyan, Ohshiro, Kazufumi, Zaidi, Sobia, Yang, Xiaochun, Bhowmick, Krishanu, Vegesna, Anil K., Bernstein, David, Crawford, James M., Mishra, Bibhuti, Latham, Patricia S., Gough, Nancy R., Rao, Shuyun, Mishra, Lopa

    Published in The FASEB journal (01-06-2022)
    “…Dysregulated transforming growth factor‐beta (TGF‐β) signaling contributes to fibrotic liver disease and hepatocellular cancer (HCC), both of which are…”
    Get full text
    Journal Article
  12. 12

    CD137 agonist potentiates the abscopal efficacy of nanoparticle-based photothermal therapy for melanoma by Balakrishnan, Preethi Bala, Ledezma, Debbie K., Cano-Mejia, Juliana, Andricovich, Jaclyn, Palmer, Erica, Patel, Vishal A., Latham, Patricia S., Yvon, Eric S., Villagra, Alejandro, Fernandes, Rohan, Sweeney, Elizabeth E.

    Published in Nano research (01-03-2022)
    “…Despite the promise of immunotherapy such as the immune checkpoint inhibitors (ICIs) anti-PD-1 and anti-CTLA-4 for advanced melanoma, only 26%–52% of patients…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Downregulation of miR-375 contributes to ERBB2-mediated VEGFA overexpression in esophageal cancer by Ren, Shuchang, Tan, Xiaohui, Fu, Melinda Z., Ren, Shuyang, Wu, Xiaoling, Chen, Tao, Latham, Patricia S., Lin, Paul, Man, Yan-gao, Fu, Sidney W.

    Published in Journal of Cancer (01-01-2021)
    “…Esophageal cancer (EC) is a lethal cancer with an extremely aggressive nature and poor survival rate. However, the molecular mechanisms driving the occurrence…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer by Zaidi, Sobia, Amdur, Richard, Xiang, Xiyan, Yu, Herbert, Wong, Linda L, Rao, Shuyun, He, Aiwu R, Amin, Karan, Zaheer, Daewa, Narayan, Raj K, Satapathy, Sanjaya K, Latham, Patricia S, Shetty, Kirti, Guha, Chandan, Gough, Nancy R, Mishra, Lopa

    Published in Genes & cancer (2022)
    “…Hepatocellular carcinoma (HCC) is the primary form of liver cancer and a major cause of cancer death worldwide. Early detection is key to effective treatment…”
    Get full text
    Journal Article
  18. 18

    microRNA-196b promotes esophageal squamous cell carcinogenesis and chemoradioresistance by inhibiting EPHA7, thereby restoring EPHA2 activity by Tan, Xiaohui, Ren, Shuchang, Fu, Melinda Z, Ren, Shuyang, Yang, Canyuan, Wu, Xiaoling, Chen, Tao, Latham, Patricia S, Meltzer, Stephen J, Fu, Sidney W

    Published in American journal of cancer research (01-01-2021)
    “…Esophageal cancer (EC) is extremely aggressive and has a very poor survival rate. Esophageal squamous cell carcinoma (ESCC) accounts for 80% of all ECs…”
    Get full text
    Journal Article
  19. 19

    Hepatic fibrosis and immune phenotype vary by HCV viremia in HCV/HIV co-infected subjects: A Women's interagency HIV study by Desai, Seema N., Dodge, Jennifer L., Landay, Alan L., Glesby, Marshall J., Latham, Patricia S., Villacres, Maria C., French, Audrey L., Gange, Stephen J., Greenblatt, Ruth M., Peters, Marion G.

    Published in Medicine (Baltimore) (01-08-2016)
    “…HCV and HIV independently lead to immune dysregulation. The mechanisms leading to advanced liver disease progression in HCV/HIV coinfected subjects remain…”
    Get full text
    Journal Article
  20. 20

    Resistin expression correlates with steatohepatitis in morbidly obese patients by Edwards, Claire R., Hindle, A. Katharine, Latham, Patricia S., Fu, Sidney W., Brody, Fred J.

    Published in Surgical endoscopy (01-04-2013)
    “…Background Morbidly obese patients are at risk for nonalcoholic steatohepatitis (NASH) even in the absence of risk factors for liver disease. Unfortunately,…”
    Get full text
    Journal Article